Terms: = Germ cell tumor AND RAC1, ENSG00000136238, 5879, MIG5, MGC111543, P63000, p21-Rac1, TC-25 AND Prognosis
31 results:
1. Tiam1 regulates proliferation, invasion, and differentiation in neuroblastoma through the Tiam1/rac1 signaling pathway.
Li X; Liu B; Wang X; Zhuang Y; Gao T; Sun N
Neoplasma; 2024 Feb; 71(1):37-47. PubMed ID: 38506031
[TBL] [Abstract] [Full Text] [Related]
2. Unique vulnerability of rac1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints.
Cannon AC; Budagyan K; Uribe-Alvarez C; Kurimchak AM; Araiza-Olivera D; Cai KQ; Peri S; Zhou Y; Duncan JS; Chernoff J
Oncogene; 2024 Mar; 43(10):729-743. PubMed ID: 38243078
[TBL] [Abstract] [Full Text] [Related]
3. PAK1 and Therapy Resistance in Melanoma.
Kichina JV; Maslov A; Kandel ES
Cells; 2023 Sep; 12(19):. PubMed ID: 37830586
[TBL] [Abstract] [Full Text] [Related]
4. Primary mucosal melanomas of the urogenital tract: a clinical, pathological, and genetic nationwide survey of Danish patients 1990-2019.
Znaider VK; Mikkelsen LH; Jensen CFS; Sønksen J; Heegaard S
Scand J Urol; 2023 Aug; 58():52-59. PubMed ID: 37635444
[TBL] [Abstract] [Full Text] [Related]
5. A comprehensive signature based on endoplasmic reticulum stress-related genes in predicting prognosis and immunotherapy response in melanoma.
Liu L; Yao D; Chen Z; Duan S
Sci Rep; 2023 May; 13(1):8232. PubMed ID: 37217516
[TBL] [Abstract] [Full Text] [Related]
6. A distinct pattern of growth and rac1 signaling in melanoma brain metastasis cells.
Stejerean-Todoran I; Gimotty PA; Watters A; Brafford P; Krepler C; Godok T; Li H; Bonilla Del Rio Z; Zieseniss A; Katschinski DM; Sertel SM; Rizzoli SO; Garman B; Nathanson KL; Xu X; Chen Q; Oswald JH; Lotem M; Mills GB; Davies MA; Schön MP; Bogeski I; Herlyn M; Vultur A
Neuro Oncol; 2023 Apr; 25(4):674-686. PubMed ID: 36054930
[TBL] [Abstract] [Full Text] [Related]
7. FMRP ligand circZNF609 destabilizes rac1 mRNA to reduce metastasis in acral melanoma and cutaneous melanoma.
Shang Q; Du H; Wu X; Guo Q; Zhang F; Gong Z; Jiao T; Guo J; Kong Y
J Exp Clin Cancer Res; 2022 May; 41(1):170. PubMed ID: 35534866
[TBL] [Abstract] [Full Text] [Related]
8. Rhoj Is a Novel Target for Progression and Invasion of Glioblastoma by Impairing Cytoskeleton Dynamics.
Wang M; Jiang X; Yang Y; Chen H; Zhang C; Xu H; Qi B; Yao C; Xia H
Neurotherapeutics; 2020 Oct; 17(4):2028-2040. PubMed ID: 32822001
[TBL] [Abstract] [Full Text] [Related]
9. Bioinformatic analysis of the potential molecular mechanism of PAK7 expression in glioblastoma.
Wang X; Liu S; Shao Z; Zhang P
Mol Med Rep; 2020 Aug; 22(2):1362-1372. PubMed ID: 32626960
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic risk model construction and molecular marker identification in glioblastoma multiforme based on mRNA/microRNA/long non-coding RNA analysis using random survival forest method.
Wang H; Liu D; Yang J
Neoplasma; 2019 May; 66(3):459-469. PubMed ID: 30784292
[TBL] [Abstract] [Full Text] [Related]
11. ARL4C stabilized by AKT/mTOR pathway promotes the invasion of PTEN-deficient primary human glioblastoma.
Chen Q; Weng HY; Tang XP; Lin Y; Yuan Y; Li Q; Tang Z; Wu HB; Yang S; Li Y; Zhao XL; Fu WJ; Niu Q; Feng H; Zhang X; Wang Y; Bian XW; Yao XH
J Pathol; 2019 Feb; 247(2):266-278. PubMed ID: 30357833
[TBL] [Abstract] [Full Text] [Related]
12. TRPV4 promotes the migration and invasion of glioma cells via AKT/rac1 signaling.
Ou-Yang Q; Li B; Xu M; Liang H
Biochem Biophys Res Commun; 2018 Sep; 503(2):876-881. PubMed ID: 29928875
[TBL] [Abstract] [Full Text] [Related]
13. The role of miR-451 in the switching between proliferation and migration in malignant glioma cells: AMPK signaling, mTOR modulation and rac1 activation required.
Zhao K; Wang L; Li T; Zhu M; Zhang C; Chen L; Zhao P; Zhou H; Yu S; Yang X
Int J Oncol; 2017 Jun; 50(6):1989-1999. PubMed ID: 28440461
[TBL] [Abstract] [Full Text] [Related]
14. The role of FilGAP, a Rac-specific Rho-GTPase-activating protein, in tumor progression and behavior of astrocytomas.
Hara A; Hashimura M; Tsutsumi K; Akiya M; Inukai M; Ohta Y; Saegusa M
Cancer Med; 2016 Dec; 5(12):3412-3425. PubMed ID: 27790861
[TBL] [Abstract] [Full Text] [Related]
15. Genetic Determinants of Cisplatin Resistance in Patients With Advanced germ cell tumors.
Bagrodia A; Lee BH; Lee W; Cha EK; Sfakianos JP; Iyer G; Pietzak EJ; Gao SP; Zabor EC; Ostrovnaya I; Kaffenberger SD; Syed A; Arcila ME; Chaganti RS; Kundra R; Eng J; Hreiki J; Vacic V; Arora K; Oschwald DM; Berger MF; Bajorin DF; Bains MS; Schultz N; Reuter VE; Sheinfeld J; Bosl GJ; Al-Ahmadie HA; Solit DB; Feldman DR
J Clin Oncol; 2016 Nov; 34(33):4000-4007. PubMed ID: 27646943
[TBL] [Abstract] [Full Text] [Related]
16. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
van de Nes J; Gessi M; Sucker A; Möller I; Stiller M; Horn S; Scholz SL; Pischler C; Stadtler N; Schilling B; Zimmer L; Hillen U; Scolyer RA; Buckland ME; Lauriola L; Pietsch T; Waha A; Schadendorf D; Murali R; Griewank KG
J Neurooncol; 2016 May; 127(3):435-44. PubMed ID: 26744134
[TBL] [Abstract] [Full Text] [Related]
17. Propentofylline inhibits glioblastoma cell invasion and survival by targeting the TROY signaling pathway.
Dhruv HD; Roos A; Tomboc PJ; Tuncali S; Chavez A; Mathews I; Berens ME; Loftus JC; Tran NL
J Neurooncol; 2016 Feb; 126(3):397-404. PubMed ID: 26559543
[TBL] [Abstract] [Full Text] [Related]
18. MT1-MMP dependent repression of the tumor suppressor SPRY4 contributes to MT1-MMP driven melanoma cell motility.
Shaverdashvili K; Zhang K; Osman I; Honda K; Jobava R; Bedogni B
Oncotarget; 2015 Oct; 6(32):33512-22. PubMed ID: 26392417
[TBL] [Abstract] [Full Text] [Related]
19. Autocrine IL-8 promotes F-actin polymerization and mediate mesenchymal transition via ELMO1-NF-κB-Snail signaling in glioma.
Zhang B; Shi L; Lu S; Sun X; Liu Y; Li H; Wang X; Zhao C; Zhang H; Wang Y
Cancer Biol Ther; 2015; 16(6):898-911. PubMed ID: 25870011
[TBL] [Abstract] [Full Text] [Related]
20. Identification of metastasis-suppressive microRNAs in primary melanoma.
Hanniford D; Segura MF; Zhong J; Philips E; Jirau-Serrano X; Darvishian F; Berman RS; Shapiro RL; Pavlick AC; Brown B; Osman I; Hernando E
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25677173
[TBL] [Abstract] [Full Text] [Related]
[Next]